Age at first full-term pregnancy and mammographic breast density in postmenopausal women: a systematic review

While mammographic breast density (MBD) is a well-established independent risk factor for breast cancer and age at first full-term pregnancy (FFTP) has been identified as a protective factor, there are very few high-quality studies that address the relationship between these two variables. The goal of this work was to generate a systematic review of published studies that addresses the association between age at FFTP and MBD based on objective mammographic findings in postmenopausal women. The English-language literature published with a cutoff date 31 August 2022 in the PubMed, EMBASE, Scopus, Web of Science, and Cochrane Library databases was searched using relevant keywords. The Newcastle-Ottawa Quality Assessment Scale was used to assess the quality of all relevant studies identified in this search. Our search yielded 12 original publications (including one conference abstract) that focused on the impact of age at FFTP on MBD in studies that objectively evaluated this condition in women without any form of breast pathology. Of these, six studies revealed a direct association between older age at FFTP and higher MBD in postmenopausal women. The remaining six studies reported either no relationship between these parameters or revealed an inverse association between MBD and older age at FFTP. We concluded that half of the currently-published findings supported an association between older age at FFTP and higher MBD. However, substantial heterogeneity between FFTP and MBD might be explained by different racial clusters, lacking specific information of other reproductive factors and differences in methodology utilized. The goal of this work was to examine whether age at FFTP is associated with MBD in postmenopausal women.

First full-term pregnancy; Menopause; Mammographic breast density; Breast cancer risk

[1] Subramani R, Lakshmanaswamy R. Pregnancy and breast cancer. Progress in Molecular Biology and Translational Science. 2017; 151: 81–111.

[2] Nazari SS, Mukherjee P. An overview of mammographic density and its association with breast cancer. Breast Cancer. 2018; 25: 259–267.

[3] World Health Organization. Breast Cancer. 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/breast-cancer (26 March 2021).

[4] Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Communications. 2021; 41: 1183–1194.

[5] Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, et al. Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. International Journal of Cancer. 2012; 131: 1059–1070.

[6] Russo J, Russo IH. Molecular basis of breast cancer prevention and treatment. 1st ed. Springer: Berlin, Heidelberg. 2004.

[7] MUSTACCHI P. Ramazzini and Rigoni—stern on parity and breast cancer. Clinical impression and statistical corroboration. Archives of Internal Medicine. 1961; 108: 639–642.

[8] MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, et al. Age at first birth and breast cancer risk. Bulletin of the World Health Organization. 1970; 43: 209–221.

[9] Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, et al. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiology, Biomarkers & Prevention. 2008; 17: 43–50.

[10] Schonfeld SJ, Pfeiffer RM, Lacey JV Jr, Berrington de González A, Doody MM, Greenlee RT, et al. Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: an aggregated study. American Journal of Epidemiology. 2011; 173: 509–517.

[11] Katz TA. Potential mechanisms underlying the protective effect of pregnancy against breast cancer: a focus on the IGF pathway. Frontiers in Oncology. 2016; 6: 228.

[12] Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, et al. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiology, Biomarkers & Prevention. 2008; 17: 1723–1730.

[13] Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, et al. Differences in mammographic density between Asian and Caucasian populations: a comparative analysis. Breast Cancer Research and Treatment. 2017; 161: 353–362.

[14] American College of Radiology. ACR BI-RADS atlas : breast imaging reporting and data system. 5th ed. American College of Radiology: Reston, VA. 2013.

[15] Loehberg CR, Heusinger K, Jud SM, Haeberle L, Hein A, Rauh C, et al. Assessment of mammographic density before and after first full-term pregnancy. European Journal of Cancer Prevention. 2010; 19: 405–412.

[16] Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Research. 2011; 13: 223.

[17] Hsu W, Zhou X, Petruse A, Chau N, Lee-Felker S, Hoyt A, et al. Role of clinical and imaging risk factors in predicting breast cancer diagnosis among BI-RADS 4 cases. Clinical Breast Cancer. 2019; 19: e142–e151.

[18] Nishiyama K, Taira N, Mizoo T, Kochi M, Ikeda H, Iwamoto T, et al. Influence of breast density on breast cancer risk: a case control study in Japanese women. Breast Cancer. 2020; 27: 277–283.

[19] Masala G, Ambrogetti D, Assedi M, Bendinelli B, Caini S, Palli D. Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case-control study in the EPIC Florence cohort. Breast Cancer Research and Treatment. 2017; 164: 467–473.

[20] Destounis S, Arieno A, Morgan R, Roberts C, Chan A. Qualitative versus quantitative mammographic breast density assessment: applications for the US and abroad. Diagnostics. 2017; 7: 30.

[21] Duffy SW, Morrish OWE, Allgood PC, Black R, Gillan MGC, Willsher P, et al. Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer. European Journal of Cancer. 2018; 88: 48–56.

[22] Janssens JP, Vandeloo MJ. Breast cancer: a life-time disease direct and indirect age-related lifestyle risk factors. Nowotwory Journal of Oncology. 2009; 59: 159–167.

[23] Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR. American Journal of Roentgenology. 1976; 126: 1130–1137.

[24] Bravi F, Decarli A, Russo AG. Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study. Cancer Medicine. 2018; 7: 2145–2152.

[25] Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, et al. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Research and Treatment. 2018; 170: 129–141.

[26] Alexeeff SE, Odo NU, McBride R, McGuire V, Achacoso N, Rothstein JH, et al. Reproductive factors and mammographic density: associations among 24,840 women and comparison of studies using digitized film-screen mammography and full-field digital mammography. American Journal of Epidemiology. 2019; 188: 1144–1154.

[27] Cohn BA, Terry MB. Environmental influences on mammographic breast density in california: a strategy to reduce breast cancer risk. International Journal of Environmental Research and Public Health. 2019; 16: 4731.

[28] Lynge E, Vejborg I, Andersen Z, von Euler-Chelpin M, Napolitano G. Mammographic density and screening sensitivity, breast cancer incidence and associated risk factors in danish breast cancer screening. Journal of Clinical Medicine. 2019; 8: 2021.

[29] Moran O, Eisen A, Demsky R, Blackmore K, Knight JA, Panchal S, et al. Predictors of mammographic density among women with a strong family history of breast cancer. BMC Cancer. 2019; 19: 631.

[30] Napolitano G, Lynge E, Lillholm M, Vejborg I, van Gils CH, Nielsen M, et al. Change in mammographic density across birth cohorts of Dutch breast cancer screening participants. International Journal of Cancer. 2019; 145: 2954–2962.

[31] Rebolj M, Blyuss O, Chia KS, Duffy SW. Long-term excess risk of breast cancer after a single breast density measurement. European Journal of Cancer. 2019; 117: 41–47.

[32] Paterson E, Havrda JB. Breast density: assessment, cancer risk, and reporting regulations. Radiologic Technology. 2020; 91: 361M–375M.

[33] Mokhtary A, Karakatsanis A, Valachis A. Mammographic density changes over time and breast cancer risk: a systematic review and meta-analysis. Cancers. 2021;13: 4805.

[34] McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiology, Biomarkers & Prevention. 2006; 15: 1159–1169.

[35] Pettersson A, Graff RE, Ursin G, dos Santos Silva I, McCormack V, Baglietto L, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. Journal of the National Cancer Institute. 2014; 106: dju078.

[36] Ursin G, Lillie EO, Lee E, Cockburn M, Schork NJ, Cozen W, et al. The relative importance of genetics and environment on mammographic density. Cancer Epidemiology, Biomarkers & Prevention. 2009; 18: 102–112.

[37] Rice MS, Bertrand KA, Lajous M, Tamimi RM, Torres G, López-Ridaura R, et al. Reproductive and lifestyle risk factors and mammographic density in Mexican women. Annals of Epidemiology. 2015; 25: 868–873.

[38] Lee E, Doanvo N, Lee M, Soe Z, Lee AW, Van Doan C, et al. Immigration history, lifestyle characteristics, and breast density in the Vietnamese American women’s health study: a cross-sectional analysis. Cancer Causes & Control. 2020; 31: 127–138.

[39] Kerlikowske K, Phipps AI. Breast density influences tumor subtypes and tumor aggressiveness. Journal of the National Cancer Institute. 2011; 103: 1143–1145.

[40] Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. Journal of the National Cancer Institute. 2011; 103: 1179–1189.

[41] Nazari SS, Mukherjee P. An overview of mammographic density and its association with breast cancer. Breast Cancer. 2018; 25: 259–267.

[42] Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiology, Biomarkers & Prevention. 2002; 11: 1048–1153.

[43] Mobbs CV. Reproductive Senescence, Human. In Knobil E, Skinner K, Neill JD (ed). Encyclopedia of Reproduction (pp 232–233). 1st ed. Academic Press: New York. 1998.

[44] Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine. 2009; 6: e1000097.

[45] Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Laboratory Investigation. 2000. Available at: http://www.ohri.ca/programs/clinical_ epidemiology/oxford.asp (1 March 2023).

[46] Heusinger K, Loehberg CR, Haeberle L, Jud SM, Klingsiek P, Hein A, et al. Mammographic density as a risk factor for breast cancer in a German case-control study. European Journal of Cancer Prevention. 2011; 20: 1–8.

[47] Sung J, Song Y, Stone J, Lee K, Lee D. Reproductive factors associated with mammographic density: a Korean co-twin control study. Breast Cancer Research and Treatment. 2011; 128: 567–572.

[48] Yaghjyan L, Colditz GA, Rosner B, Bertrand KA, Tamimi RM. Reproductive factors related to childbearing and mammographic breast density. Breast Cancer Research and Treatment. 2016; 158: 351–359.

[49] Rice MS, Bertrand KA, Lajous M, Tamimi RM, Torres-Mejía G, Biessy C, et al. Body size throughout the life course and mammographic density in Mexican women. Breast Cancer Research and Treatment. 2013; 138: 601–610.

[50] Mariapun S, Li J, Yip CH, Taib NA, Teo SH. Ethnic differences in mammographic densities: an Asian cross-sectional study. PLoS One. 2015; 10: e0117568.

[51] Prebil LA, Ereman RR, Powell MJ, Jamshidian F, Kerlikowske K, Shepherd JA, et al. First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes & Control. 2014; 25: 859–868.

[52] Hjerkind KV, Ellingjord-Dale M, Johansson ALV, Aase HS, Hoff SR, Hofvind S, et al. Volumetric mammographic density, age-related decline, and breast cancer risk factors in a national breast cancer screening program. Cancer Epidemiology, Biomarkers & Prevention. 2018; 27: 1065–1074.

[53] Vandeloo MJ, Neven KY, Bruckers LM, Russo J, Vancoullie L, Bijnens E, et al. Age of first full term pregnancy and other reproductive factors affect mammographic breast density in postmenopausal women. The 2020 San Antonio Breast Cancer Symposium. San Antonio, TX and 8–11 December 2020. AACR: Philadelphia. 2021.

[54] Vandeloo MJ, Neven KY, Bruckers LM, Russo J, Vancoullie L, Bijnens E, et al. Mammographic breast density in postmenopausal women is affected by the age of first full term pregnancy. Proceedings of the American Association for Cancer Research Annual Meeting 2019. Atlanta, GA and 29 March 2019–03 April 2019. AACR: Atlanta, GA. 2019.

[55] Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, et al. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Research. 2014; 16: 439.

[56] Rao VM, Levin DC, Parker L, Cavanaugh B, Frangos AJ, Sunshine JH. How widely is computer-aided detection used in screening and diagnostic mammography? Journal of the American College of Radiology. 2010; 7: 802–805.

[57] Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, et al. Variability in interpretive performance at screening mammography and radiologists’ characteristics associated with accuracy. Radiology. 2009; 253: 641–651.

[58] Houssami N, Hunter K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer. 2017; 3: 12.

[59] Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. Breast. 2022; 64: 85–99.

[60] Riza E, Remoundos DD, Bakali E, Karadedou-Zafiriadou E, Linos D, Linos A. Anthropometric characteristics and mammographic parenchymal patterns in post-menopausal women: a population-based study in Northern Greece. Cancer Causes & Control. 2009; 20: 181–191.

[61] Yen AM, Wu WY, Tabar L, Duffy SW, Smith RA, Chen H. Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer. Journal of Epidemiology. 2017; 27: 98–106.

[62] Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes & Control. 2000; 11: 653–662.

[63] Caglayan EK, Caglayan K, Alkis I, Arslan E, Okur A, Banli O, et al. Factors associated with mammographic density in postmenopausal women. Journal of Menopausal Medicine. 2015; 21: 82–88.

[64] Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prevention Research. 2014; 7: 211–217.

[65] Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast—risk assessment and management options. The New England Journal of Medicine. 2015; 372: 78–89.

[66] Russo J, Russo IH. DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. Journal of the National Cancer Institute. 1978; 61: 1451–1459.

[67] Russo J, Russo IH. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Research. 1980; 40: 2677–2687.

[68] Yaghjyan L, Austin-Datta RJ, Oh H, Heng YJ, Vellal AD, Sirinukunwattana K, et al. Associations of reproductive breast cancer risk factors with breast tissue composition. Breast Cancer Research. 2021; 23: 70.

[69] Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer. 2006; 6: 170.

[70] Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiology, Biomarkers & Prevention. 2008; 17: 51–66.

[71] Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S, Talamantes F. Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis. 1995; 16: 2847–2853.

[72] Sinha DK, Pazik JE, Dao TL. Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. British Journal of Cancer. 1988; 57: 390–394.

[73] Fisher DA. Fetal and neonatal endocrinology. Endocrinology. 2010; 148: 2624–2643.

[74] Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. Journal of the National Cancer Institute. 1978; 61: 1439–1449.

[75] Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Research. 2005; 7: 131–142.

[76] Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S, et al. Genomic signature of parity in the breast of premenopausal women. Breast Cancer Research. 2019; 21: 46.

[77] Gutierrez-Diez PJ, Gomez-Pilar J, Hornero R, Martinez-Rodriguez J, Lopez-Marcos MA, Russo J. The role of gene to gene interaction in the breast’s genomic signature of pregnancy. Scientific Reports. 2021; 11: 2643.

[78] Peri S, de Cicco RL, Santucci-Pereira J, Slifker M, Ross EA, Russo IH, et al. Defining the genomic signature of the parous breast. BMC Medical Genomics. 2012; 5: 46.

[79] Holmes MD, Pollak MN, Hankinson SE. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiology, Biomarkers & Prevention. 2002; 11: 862–867.

[80] Endogenous Hormones and Breast Cancer Collaborative Group; Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. The Lancet. Oncology. 2010; 11: 530–542.

[81] Russo J, Santucci-Pereira J, Russo IH. The genomic signature of breast cancer prevention. Genes. 2014; 5: 65–83.